Reduced inter‐ and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation

Journal of Pharmaceutical Sciences

Volumn 83, Issue 3, 1994, Pages 444-446

  Kovarik, John M ^a   Mueller, Edgar A ^a   Van Bree, Johannes B ^a   Tetzloff, Wolfgang ^b   Kutz, Klaus ^a  

^a Sandoz Pharma Ltd   (Switzerland)

^b Iphar Crf Institute for Clinical Pharmacology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; HUMAN; HUMAN EXPERIMENT; IMMUNOSUPPRESSIVE TREATMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RADIOIMMUNOASSAY;

ADULT; ANTIBODIES, MONOCLONAL; COMPARATIVE STUDY; CYCLOSPORINE; EMULSIONS; HALF-LIFE; HUMAN; MALE; RADIOIMMUNOASSAY;

EID: 0028335905     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.2600830336     Document Type: Article

References (11)

1. Absorption of cyclosporine A after oral dosing.